Literature DB >> 8639596

RNA conformation in the Tat-TAR complex determined by site-specific photo-cross-linking.

Z Wang1, T M Rana.   

Abstract

Transcriptional regulation in human immunodeficiency virus type 1 (HIV-1) requires specific interactions of Tat protein with the transactivation responsive region (TAR) RNA, a 59-base stem-loop structure located at the 5'-end of all mRNAs. We have used a site-specific cross-linking method based on 4-thiouracil (4-thioU) photochemistry to determine the conformation of TAR RNA and its interaction with Tat protein under physiological conditions. Three different TAR RNA constructs with a single 4-thioU residue at position 23, 38, or 40 were synthesized. Upon UV irradiation, 4-thioU at all three positions formed interstrand covalent cross-links in TAR RNA. Determination of cross-link sites by RNA sequencing revealed that 4-thioU at position 23 makes a direct contact with U40, while a 4-thoU at position 40 cross-links to C24 and C25, and at position 38, 4-thioU contacts G26 in TAR RNA. The addition of arginine did not alter the yield or the site of RNA-RNA cross-link. However, in the presence of Tat(38-72), UV irradiation of RNA modified with 4-thioU at position 23 or 38 resulted in RNA- protein cross-links, but no RNA-RNA cross-links were observed. 4-thioU at position 40 formed both RNA-RNA and RNA-protein cross-links in the presence of Tat(38-72). An intriguing finding of our studies was that a cross-linked TAR RNA with 4-thioU at position 40 retained specific Tat-binding activity. Our results establish four important conclusions about Tat-TAR structure. (1) U23 of free TAR RNA is in close contact with U40. (2) U40 is in close proximity to C24 and C25 both in free TAR RNA and in a complex with Tat. (3) Tat protein directly contacts U23, U38, and U40 in the major groove of TAR RNA. (4) Tat protein can recognize a TAR RNA structure containing an interrupted bulge which is formed by a covalent link between U40 and two bulge residues, C24 and C25. These structural studies provide new insights into tertiary folding of TAR RNA and its interaction with Tat protein.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8639596     DOI: 10.1021/bi960037p

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Inhibition of gene expression in human cells through small molecule-RNA interactions.

Authors:  S Hwang; N Tamilarasu; K Ryan; I Huq; S Richter; W C Still; T M Rana
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

2.  Binding of Hoechst 33258 to the TAR RNA of HIV-1. Recognition of a pyrimidine bulge-dependent structure.

Authors:  L Dassonneville; F Hamy; P Colson; C Houssier; C Bailly
Journal:  Nucleic Acids Res       Date:  1997-11-15       Impact factor: 16.971

3.  RNA-protein crosslinking to AMP residues at internal positions in RNA with a new photocrosslinking ATP analog.

Authors:  C Costas; E Yuriev; K L Meyer; T S Guion; M M Hanna
Journal:  Nucleic Acids Res       Date:  2000-05-01       Impact factor: 16.971

4.  An ab initio and AIM investigation into the hydration of 2-thioxanthine.

Authors:  Xiu-Xiang Yuan; Yan-Fang Wang; Xin Wang; Wenbo Chen; John S Fossey; Ning-Bew Wong
Journal:  Chem Cent J       Date:  2010-03-23       Impact factor: 4.215

5.  U30 of 7SK RNA forms a specific photo-cross-link with Hexim1 in the context of both a minimal RNA-binding site and a fully reconstituted 7SK/Hexim1/P-TEFb ribonucleoprotein complex.

Authors:  François Bélanger; Huricha Baigude; Tariq M Rana
Journal:  J Mol Biol       Date:  2009-03-06       Impact factor: 5.469

6.  Dynamics of nascent mRNA folding and RNA-protein interactions: an alternative TAR RNA structure is involved in the control of HIV-1 mRNA transcription.

Authors:  Sara N Richter; François Bélanger; Ping Zheng; Tariq M Rana
Journal:  Nucleic Acids Res       Date:  2006-08-18       Impact factor: 16.971

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.